Bull/Bear Index 46.3/100
→
crypto
15/10
TokenPost · 1h ago
Osangcotech Shares Strong on News of KRW 1 Trillion Technology Transfer Deal with Agios
Osangcotech is showing strength following news of a large-scale technology transfer agreement for its autoimmune disease treatment candidate, Cevidoplenib, with NASDAQ-listed Agios Pharmaceuticals, including an upfront payment of $25 million and up to $665 million in milestones.
Get the next 8/10 catalyst
Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.0%.
Join Telegram channel
or scan with phone →
